Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent

被引：0
|
作者：
Williams, D. [1 ]
Gana, T. [1 ]
Sivapalan, L. [1 ]
Butler, O. [1 ]
Jackson, R. [1 ]
Perez-Mancera, P. [1 ]
Barrera-Briceno, L. [1 ]
Copple, I. [1 ]
Cox, T. [1 ]
Goldring, C. [1 ]
Halloran, C. M. [1 ]
Ghaneh, P. [1 ]
Palmer, D. [1 ]
Strobel, O. [2 ]
Greenhalf, W. [1 ]
Neoptolemos, J. P. [1 ]
Costello, E. [1 ]
机构：
[1] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[2] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
来源：
PANCREAS | 2017年 / 46卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1443 / 1443
页数：1
相关论文
共 50 条
  • [1] Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
    Xiang, Yukai
    Ye, Wen
    Huang, Chaohao
    Yu, Dinglai
    Chen, Hao
    Deng, Tuo
    Zhang, Fan
    Lou, Bin
    Zhang, Jie
    Shi, Keqing
    Chen, Bicheng
    Zhou, Mengtao
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [2] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Cai, Sabrina J.
    Liu, Yang
    Han, Sue
    Yang, Chunzhang
    CELL AND BIOSCIENCE, 2019, 9 (1):
  • [3] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Sabrina J. Cai
    Yang Liu
    Sue Han
    Chunzhang Yang
    Cell & Bioscience, 9
  • [4] Brusatol Strengthens the Efficacy of Gemcitabine in Pancreatic Cancer: Involvement of NRF2 and NF-κB Signaling Pathways
    Xiang, Y.
    Yu, D.
    Wu, M.
    Chen, B.
    Zhou, M.
    PANCREAS, 2018, 47 (05) : 530 - 530
  • [5] Role of Nrf2 in Pancreatic Cancer
    Cykowiak, Marta
    Krajka-Kuzniak, Violetta
    ANTIOXIDANTS, 2022, 11 (01)
  • [6] Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
    Wang, Xiao-Jun
    Sun, Zheng
    Villeneuve, Nicole F.
    Zhang, Shirley
    Zhao, Fei
    Li, Yanjie
    Chen, Weimin
    Yi, Xiaofang
    Zheng, Wenxin
    Wondrak, Georg T.
    Wong, Pak Kin
    Zhang, Donna D.
    CARCINOGENESIS, 2008, 29 (06) : 1235 - 1243
  • [7] Nrf2 promotes mRNA translation in pancreatic cancer
    Chio, Iok In Christine
    Jafarnejad, Seyed Mehdi
    Ponz-Sarvise, Mariano
    Rivera, Keith
    Ohlund, Daniel
    Sangar, Vineet
    Wright, Kevin
    Fillippi, Dea
    Hao, Yuan
    Wilkinson, John Erby
    Tiriac, Herve
    Hammell, Molly
    Schmidt, Edward
    Park, Youngkyu
    Pappin, Darryl
    Sonenberg, Nahum
    Tuveson, David
    CANCER RESEARCH, 2016, 76
  • [8] Brusatol inhibits the invasion and migration of pancreatic cancer cells by suppressing the NRF2/NF-κB/STAT3 signal cascade
    Xiang, Yukai
    Dai, Shengjie
    Li, Ding
    Zhu, Xiandong
    Su, Jiadong
    Chen, Bicheng
    Wu, Minmin
    JOURNAL OF FUNCTIONAL FOODS, 2022, 92
  • [9] Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2
    Gong, Z.
    Xue, L.
    Vlantis, A. C.
    van Hasselt, C. A.
    Chan, J. Y. K.
    Fang, J.
    Wang, R.
    Yang, Y.
    Li, D.
    Zeng, X.
    Tong, M. C. F.
    Chen, G. G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (05) : 1271 - 1280
  • [10] Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2
    Z. Gong
    L. Xue
    A. C. Vlantis
    C. A. van Hasselt
    J. Y. K. Chan
    J. Fang
    R. Wang
    Y. Yang
    D. Li
    X. Zeng
    M. C. F. Tong
    G. G. Chen
    Journal of Endocrinological Investigation, 2024, 47 : 1271 - 1280
12345